Skip to main content
Top
Published in: Familial Cancer 1/2013

01-03-2013 | Original Article

Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors

Authors: Isabelle Sourrouille, Florence Coulet, Jeremie H. Lefevre, Chrystelle Colas, Mélanie Eyries, Magali Svrcek, Armelle Bardier-Dupas, Yann Parc, Florent Soubrier

Published in: Familial Cancer | Issue 1/2013

Login to get access

Abstract

Some patients happen to have a colorectal cancer with microsatellite instability (MSI), but without any alteration in Mismatch Repair (MMR) system (germline mutation/promoter methylation). We aimed to identify the mechanism of inactivation of MMR genes in those cases. We studied 18 patients with MSI CCR and loss of expression of a MMR protein. DNA was extracted from tumoral and normal colonic material. We studied the 3 main MMR genes in tumors, by sequencing and large rearrangement analysis, and looked for mosaicism. Seven patients lost expression of MLH1, we found 1 mutation in the tumor for 3 patients and 2 mutations in one. Eight patients lost expression of MSH2: we found 1 mutation in 2 patients and 2 mutations in four. In the 5 cases with 2 hits, MSI was due to double somatic hits (n = 3), mosaicism (n = 1) and missed germline mutation (n = 1). Mosaicism was confirmed by HRM analysis, and by finding a germline mutation in one patient’s son. We could explain MSI in the tumors of 5 patients (27.8 %). Their follow up and family’s surveillance could be adjusted, as the sporadic cases don’t require intensive surveillance. We describe the first case of somatic mosaicism after de novo mutation in MSH2.
Literature
3.
go back to reference Perez-Carbonell L, Alenda C, Paya A, Castillejo A, Barbera VM, Guillen C, Rojas E, Acame N, Gutierrez-Avino FJ, Castells A, Llor X, Andreu M, Soto JL, Jover R (2010) Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. J Mol Diagn 12(4):498–504. doi:10.2353/jmoldx.2010.090212 PubMedCrossRef Perez-Carbonell L, Alenda C, Paya A, Castillejo A, Barbera VM, Guillen C, Rojas E, Acame N, Gutierrez-Avino FJ, Castells A, Llor X, Andreu M, Soto JL, Jover R (2010) Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. J Mol Diagn 12(4):498–504. doi:10.​2353/​jmoldx.​2010.​090212 PubMedCrossRef
4.
go back to reference Parc YR, Halling KC, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN, Halling AC (2000) Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology. Int J Cancer 86(1):60–66PubMedCrossRef Parc YR, Halling KC, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN, Halling AC (2000) Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology. Int J Cancer 86(1):60–66PubMedCrossRef
6.
go back to reference Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34(5):424–425PubMedCrossRef Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34(5):424–425PubMedCrossRef
7.
go back to reference Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S (1997) A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89(23):1758–1762PubMedCrossRef Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S (1997) A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89(23):1758–1762PubMedCrossRef
8.
go back to reference Ewald J, Rodrigue CM, Mourra N, Lefevre JH, Flejou JF, Tiret E, Gespach C, Parc YR (2007) Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer. Br J Surg 94(8):1020–1027. doi:10.1002/bjs.5704 PubMedCrossRef Ewald J, Rodrigue CM, Mourra N, Lefevre JH, Flejou JF, Tiret E, Gespach C, Parc YR (2007) Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer. Br J Surg 94(8):1020–1027. doi:10.​1002/​bjs.​5704 PubMedCrossRef
10.
11.
go back to reference Vaughn CP, Robles J, Swensen JJ, Miller CE, Lyon E, Mao R, Bayrak-Toydemir P, Samowitz WS (2010) Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes. Hum Mutat 31(5):588–593. doi:10.1002/humu.21230 PubMed Vaughn CP, Robles J, Swensen JJ, Miller CE, Lyon E, Mao R, Bayrak-Toydemir P, Samowitz WS (2010) Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes. Hum Mutat 31(5):588–593. doi:10.​1002/​humu.​21230 PubMed
12.
go back to reference Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Mecklin JP, Moller P, Nagengast F, Parc Y, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Wijnen J (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44(6):353–362. doi:10.1136/jmg.2007.048991 PubMedCrossRef Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Mecklin JP, Moller P, Nagengast F, Parc Y, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Wijnen J (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44(6):353–362. doi:10.​1136/​jmg.​2007.​048991 PubMedCrossRef
13.
go back to reference Julie C, Tresallet C, Brouquet A, Vallot C, Zimmermann U, Mitry E, Radvanyi F, Rouleau E, Lidereau R, Coulet F, Olschwang S, Frebourg T, Rougier P, Nordlinger B, Laurent-Puig P, Penna C, Boileau C, Franc B, Muti C, Hofmann-Radvanyi H (2008) Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Am J Gastroenterol 103(11):2825–2835; quiz 2836. doi:10.1111/j.1572-0241.2008.02084.x Julie C, Tresallet C, Brouquet A, Vallot C, Zimmermann U, Mitry E, Radvanyi F, Rouleau E, Lidereau R, Coulet F, Olschwang S, Frebourg T, Rougier P, Nordlinger B, Laurent-Puig P, Penna C, Boileau C, Franc B, Muti C, Hofmann-Radvanyi H (2008) Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Am J Gastroenterol 103(11):2825–2835; quiz 2836. doi:10.​1111/​j.​1572-0241.​2008.​02084.​x
14.
go back to reference Canard G, Lefevre JH, Colas C, Coulet F, Svrcek M, Lascols O, Hamelin R, Shields C, Duval A, Flejou JF, Soubrier F, Tiret E, Parc Y (2011) Screening for Lynch syndrome in colorectal cancer: are we doing enough? Ann Surg Oncol. doi:10.1245/s10434-011-2014-7 PubMed Canard G, Lefevre JH, Colas C, Coulet F, Svrcek M, Lascols O, Hamelin R, Shields C, Duval A, Flejou JF, Soubrier F, Tiret E, Parc Y (2011) Screening for Lynch syndrome in colorectal cancer: are we doing enough? Ann Surg Oncol. doi:10.​1245/​s10434-011-2014-7 PubMed
18.
go back to reference Win AK, Jenkins MA, Buchanan DD, Clendenning M, Young JP, Giles GG, Goldblatt J, Leggett BA, Hopper JL, Thibodeau SN, Lindor NM (2011) Determining the frequency of de novo germline mutations in DNA mismatch repair genes. J Med Genet 48(8):530–534. doi:10.1136/jmedgenet-2011-100082 PubMedCrossRef Win AK, Jenkins MA, Buchanan DD, Clendenning M, Young JP, Giles GG, Goldblatt J, Leggett BA, Hopper JL, Thibodeau SN, Lindor NM (2011) Determining the frequency of de novo germline mutations in DNA mismatch repair genes. J Med Genet 48(8):530–534. doi:10.​1136/​jmedgenet-2011-100082 PubMedCrossRef
19.
go back to reference Lefevre JH, Colas C, Coulet F, Bonilla C, Mourra N, Flejou JF, Tiret E, Bodmer W, Soubrier F, Parc Y (2010) MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions. Fam Cancer 9(4):589–594. doi:10.1007/s10689-010-9367-0 PubMedCrossRef Lefevre JH, Colas C, Coulet F, Bonilla C, Mourra N, Flejou JF, Tiret E, Bodmer W, Soubrier F, Parc Y (2010) MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions. Fam Cancer 9(4):589–594. doi:10.​1007/​s10689-010-9367-0 PubMedCrossRef
Metadata
Title
Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors
Authors
Isabelle Sourrouille
Florence Coulet
Jeremie H. Lefevre
Chrystelle Colas
Mélanie Eyries
Magali Svrcek
Armelle Bardier-Dupas
Yann Parc
Florent Soubrier
Publication date
01-03-2013
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2013
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-012-9568-9

Other articles of this Issue 1/2013

Familial Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine